Source link : https://www.newshealth.biz/health-news/sickle-cell-disease-drug-pulled-from-global-markets/
Pfizer is pulling its sickle cell disease (SCD) treatment voxelotor (Oxbryta) from global markets after data review showed an imbalance in deaths among patients taking the drug. “The overall benefit of the drug no longer outweighs the risk in the approved sickle cell patient population,” the company announced on Wednesday, adding that the imbalance in […]
Author : News Health
Publish date : 2024-09-26 13:16:02
Copyright for syndicated content belongs to the linked Source.
Categories